Analysis: Haleos Labs Limited

NSE:HALEOSLABS Pharmaceuticals Bulk Drugs & Formulation Market cap: ₹449 cr

Research report

companyname: SMS Lifesciences India Limited ticker: HALEOSLABS sector: Pharmaceuticals - Active Pharmaceutical Ingredients (API) SMS Lifesciences India Limited is an active pharmaceutical ingredients (API) manufacturer. The company makes bulk drugs and their intermediates, the chemical building blocks that pharmaceutical companies use to formulate finished medicines. Its two core products are Ranitidine HCL and Famotidine, both gastrointestinal drugs. The company operates in a single reportabl...

Read the full report →
RS rating: 60 Stage: Stage 3

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Haleos Labs Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.